Psychotropic medication use among patients with celiac disease
Tóm tắt
Celiac disease is a multi-system disorder with manifestations that may result in psychiatric disorders. We assessed the prevalence of medication use to treat psychiatric disorders in celiac disease patients. We conducted a cross-sectional study of patients undergoing esophagogastroduodenoscopy over 9-years at a celiac disease referral center. We compared the prevalence of psychotropic medication use among celiac disease patients (n = 1293) to a control group (n = 1401) with abdominal pain or reflux. Among all patients the mean age was 48.4 years, most were female (69.5%), and 22.7% used any psychotropic medication. There was no difference between overall psychotropic medication use among celiac disease patients and controls (23.9% vs 21.8%, OR 1.16; 95% CI 0.96–1.39, p = 0.12). However, those with celiac disease were more likely to use antidepressants on univariate (16.4% vs 13.4%, p = 0.03) and multivariate analysis (OR 1.28; 95% CI 1.03–1.59; p = 0.03). Use of psychotropic medications was not associated with disease duration or mode of presentation of celiac disease. Celiac disease patients use psychotropic medications at similar rates as those with other gastrointestinal diseases, though subgroup analysis suggests they may use more antidepressants. Future studies should investigate whether celiac disease is associated with mood disorders that are not treated with medications.
Tài liệu tham khảo
Lebwohl B, Ludvigsson JF, Green PH. Celiac disease and non-celiac gluten sensitivity. BMJ. 2015;351:h4347.
Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12:561–71.
Zingone F, Swift GL, Card TR, et al. Psychological morbidity of celiac disease: a review of the literature. United European Gastroenterol J. 2015;3:136–45.
Addolorato G, Capristo E, Ghittoni G, et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scan J Gastroenterol. 2001;36:502–6.
Carta MG, Hardoy MC, Boi MF, et al. Association between panic disorder, major depressive disorder and celiac disease:a possible role of thyroid autoimmunity. J Psychosom Res. 2002;53:789–93.
Ciacci C, Iavarone A, Mazzacca G, et al. Depressive symptoms in adult coeliac disease. Scand J Gastroenterol. 1998;33:247–50.
Ciacci C, D'Agate C, De Rosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci. 2003;48:2216–20.
Cicarelli G, Della Rocca G, Amboni M, et al. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci. 2003;24:311–7.
Fera T, Cascio B, Angelini G, et al. Affective disorders and quality of life in adult coeliac disease patients on a gluten-free diet. Eur J Gastroenterol Hepatol. 2003;15:1287–92.
Garud S, Leffler D, Dennis M, et al. Interaction between psychiatric and autoimmune disorders in coeliac disease patients in the northeastern United States. Aliment Pharmacol Ther. 2009;29:898–905.
Siniscalchi M, Iovino P, Tortora R, et al. Fatigue in adult coeliac disease. Aliment Pharmacol Ther. 2005;22:489–94.
Van Hees NJ, Van der Does W, Giltay EJ. Coeliac disease, diet adherence and depressive symptoms. J Psychosom Res. 2013;74:155–60.
Addolorato G, Stefanini GF, Capristo E, et al. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality ‘trait’ or a reactive illness. Hepato-Gastroenterology. 1996;43:1513–7.
Addolorato G, Mirijello A, D’Angelo C, et al. Social phobia in coeliac disease. Scan. J Gastroenterol. 2008;43:410–5.
Addolorato G, Mirijello A, D’Angelo C, et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008;62:1063–9.
Ciacci C, Iovino P, Amoruso D, et al. Grown-up celiac children: effects of few years on a gluten-free diet in childhood. Aliment Pharmacol Ther. 2005;21:421–9.
Ludvigsson JF, Reutfors J, Osby U, et al. Coeliac disease and risk of mood disorders—a general population-based cohort study. J Affect Disord. 2007;99(1–3):117–26.
Smith D, Gerdes LU. Meta-analysis on anxiety and depression in adult celiac disease. Acta Psychiatr Scand. 2012;125:183–93.
Carta MG, Conti A, Lecca F, et al. The burden of depressive and bipolar disorders in celiac disease. Clin Pract Epidemiol Ment Health. 2015;11:180–5.
Accomando S, Fragapane ML, Montaperto D, et al. Coeliac disease and depression: two related entities? Dig Liver Dis. 2005;37:298–9.
Hauser W, Janke KH, Klump B, et al. Anxiety and depression in adult patients with celiac disease on a gluten-free diet. World J Gastroenterol. 2010;16:2780–7.
Roos S, Karner A, Hallert C. Psychological well-being of adult coeliac patients treated for 10 years. Dig Liver Dis. 2006;38:177–80.
Collin P, Kaukinen K, Mattila AK, et al. Psychoneurotic symptoms and alexithymia in coeliac disease. Scand J Gastroenterol. 2008;43:1329–33.
Niederhofer H, Pittschieler K. A preliminary investigation of ADHD symptoms in persons with celiac disease. J Atten Disord. 2006;10:200–4.
Mårild K, Morgenthaler TI, Somers VK, et al. Increased use of hypnotics in individuals with celiac disease: a nationwide case-control study. BMC Gastroenterol. 2015;15:10.
Zingone F, Siniscalchi M, Capone P, et al. The quality of sleep in patients with coeliac disease. Aliment Pharmacol Ther. 2010;32:1031–6.
Hallert C, Grännö C, Grant C, et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 1998;33:933–8.
Hallert C, Grant C, Grehn S, et al. Evidence of poor vitamin status in coeliac patients on a gluten-free diet for 10 years. Aliment Pharmacol Ther. 2002;16:1333–9.
Hernanz A, Polanco I. Plasma precursor amino acids of central nervous system monoamines in children with coeliac disease. Gut. 1992;32:1478–81.
Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62:43–52.
Kantor ED, Rehm CD, Haas JS, et al. Trends in prescription use among adults in the United States from 1992-2012. JAMA. 2015;314:818–31.
Cossu G, Carta MG, Contu F, et al. Coeliac disease and psychiatric comorbidity: epidemiology, pathophysiological mechanisms, quality-of-life, and gluten-free diet effects. Int Rev Psychiatry. 2017;29(5):489–503.
Shah S, Akbari M, Vanga R, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–11.
Carta MG, Angst J. Screening for bipolar disorders: a public health issue. J Affect Disord. 2016;205:139–43.
Bernstein IH, Eveland DC. State vs trait anxiety: a case study in confirmatory factor analysis. Personal Individ Differ. 1982;3:361–72.
Brottveit M, Vandvik PO, Wojniusz S, et al. Absence of somatization in non-coeliac gluten sensitivity. Scand J Gastroenterol. 2012;47(7):770.
Ukkola A, Kurppa K, Collin P, et al. Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study. BMC Gastroenterol. 2012;12:136.
Ludvigsson JF, Sellgren C, Runeson B, et al. Increased suicide risk in coeliac disease--a Swedish nationwide cohort study. Dig Liver Dis. 2011;43:616–22.